These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial. Heuson JC; Sylvester R; Engelsman E Eur J Cancer (1965); 1980; Suppl 1():113-7. PubMed ID: 7032920 [No Abstract] [Full Text] [Related]
7. Benefit of the addition of paclitaxel to standard chemotherapy with 5-fluorouracil/doxorubicin/cyclophosphamide in patients with operable breast cancer. Clin Breast Cancer; 2000 Oct; 1(3):189-90. PubMed ID: 11899642 [No Abstract] [Full Text] [Related]
8. [Sequencing of adjuvant treatment after surgery for invasive breast cancer]. Petit T; Claude L; Carrie C Cancer Radiother; 2004 Feb; 8(1):54-8. PubMed ID: 15093202 [TBL] [Abstract][Full Text] [Related]
9. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer. Cavalli F; Alberto P; Jungi F; Brunner K; Martz G Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922 [No Abstract] [Full Text] [Related]
10. Financial considerations in the use of adjuvant chemotherapy. Irvin RJ; Kuhn JG Cancer Treat Res; 1992; 60():207-22. PubMed ID: 1355987 [No Abstract] [Full Text] [Related]
11. Adjuvant chemotherapy in breast cancer: back to the future. Colleoni M; Goldhirsch A Onkologie; 2003 Apr; 26(2):111-2. PubMed ID: 12771517 [No Abstract] [Full Text] [Related]
12. Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancer. Livi L; Saieva C; Borghesi S; De Luca Cardillo C; Scotti V; Mangoni M; Greto D; Cataliotti L; Paiar F; Bianchi S; Biti GP J Chemother; 2009 Nov; 21(5):558-65. PubMed ID: 19933048 [TBL] [Abstract][Full Text] [Related]
13. Breast cancer 1984: state of the art. Sledge GW Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645 [No Abstract] [Full Text] [Related]
14. Chemotherapy with or without tamoxifen in postmenopausal patients with late breast cancer. A randomized study. Boccardo F; Rubagotti A; Rosso R; Santi L J Steroid Biochem; 1985 Dec; 23(6B):1123-7. PubMed ID: 3912616 [TBL] [Abstract][Full Text] [Related]
15. The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery. Sorace RA; Bagley CS; Lichter AS; Danforth DN; Wesley MW; Young RC; Lippman ME World J Surg; 1985 Oct; 9(5):775-85. PubMed ID: 2998103 [No Abstract] [Full Text] [Related]
16. Adjuvant tamoxifen in postmenopausal stage II breast cancer five years on. Mikl J; Aiginger P; Czerwenka K; Kubista E; Salzer H; Sevelda P; Spona J; Staffen A; Zielinski CC Lancet; 1990 Mar; 335(8688):541. PubMed ID: 1968551 [No Abstract] [Full Text] [Related]
17. Combined chemo- and hormonal therapy in advanced breast cancer. Brunner KW; Sonntag RW; Alberto P; Senn HJ; Martz G; Obrecht P; Maurice P Cancer; 1977 Jun; 39(6 Suppl):2923-33. PubMed ID: 326385 [No Abstract] [Full Text] [Related]
18. Conservation therapy of breast cancer. Stewart HJ; Prescott RJ; Forrest PA Lancet; 1989 Jul; 2(8655):168-9. PubMed ID: 2567945 [No Abstract] [Full Text] [Related]
19. Clinical controlled trial in advanced breast cancer: CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CMF + T (cyclophosphamide, methotrexate, 5-fluorouracil, tamoxifen). CMEA Cooperative Treatment Group. Neoplasma; 1985; 32(3):381-7. PubMed ID: 2862594 [TBL] [Abstract][Full Text] [Related]
20. Breast cancer chemotherapy: perioperative considerations in breast reconstruction. Gargan TJ; Come SE; Satwicz PR Plast Reconstr Surg; 1985 Mar; 75(3):430-4. PubMed ID: 3919414 [No Abstract] [Full Text] [Related] [Next] [New Search]